Arkolith/Insider Trading/TPTX/Form 4

North Annette

EVP, General Counsel & Secty.Turning Point Therapeutics, Inc. (TPTX) · full profile →Form 4 · filed Aug 31, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$800K
Net Open-Market Flow
-$800K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 30, 2021Option exercise(M)10K$17.00$170K22K
Aug 30, 2021Sell(S)10K$80.00$800K12K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 30, 2021Option exercise(M)10K—$0145K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-054117) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML